Tumour-associated transplantation antigen in sera of rats with large RSV-induced sarcomas

✍ Scribed by Rashika El Ridi; Dr. H. Bubeník

• Publisher: John Wiley and Sons
• Year: 1975
• Tongue: French
• Weight: 560 KB
• Volume: 16
• Category: Article
• ISSN: 0020-7136
• DOI: 10.1002/ijc.2910160110

✦ Synopsis

Abstract

A factor inhibiting tumour growth in syngeneic hosts was found in the sera of inbred Lewis rats carrying Rous sarcoma virus‐induced tumour (RSL). The findings presented here suggest that the serum factor is a tumour‐associated transplantation antigen (TATA) shed from the neoplasm into the circulation. All the tumour‐bearers' sera tested with RSL cells were negative in indirect membrane immunofluorescence; however, on passive transfer into syngeneic rats, they protected the animals against the growth of an RSL tumour inoculum. A similar protective effect was also observed after injection of TATA prepared from RSL cell membranes by solubilization with potassium cholate. When incorporated into Freund's adjuvant, tumour‐bearers' sera immunized the animals against a subsequent RSL sarcoma graft. Sera collected from immunosuppressed rats bearing large sarcomas which presumably contain neither tumour‐specific antibody nor antigen‐antibody complexes, transferred inhibition of tumour growth to syngeneic hosts. Intact immunological reactivity of recipients was a necessary prerequisite for the protective effect of sera, since the passive transfer of an inhibitory serum to immunosuppressed rats did not inhibit tumour growth. We assume that the TATA present in tumour‐bearers' serum is released from the growing neoplasm as a result of either cell death or membrane metabolic turnover.